Cargando…
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous and the oral forms...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59641/ https://www.ncbi.nlm.nih.gov/pubmed/11806792 http://dx.doi.org/10.1186/cvm-2-4-171 |
_version_ | 1782120091946582016 |
---|---|
author | Suwaidi, Jassim Al Salam, Amar M |
author_facet | Suwaidi, Jassim Al Salam, Amar M |
author_sort | Suwaidi, Jassim Al |
collection | PubMed |
description | Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous and the oral forms. In this review, we present a systematic overview of these trials. |
format | Text |
id | pubmed-59641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-596412001-11-06 Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease Suwaidi, Jassim Al Salam, Amar M Curr Control Trials Cardiovasc Med Review Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous and the oral forms. In this review, we present a systematic overview of these trials. BioMed Central 2001 2001-07-26 /pmc/articles/PMC59641/ /pubmed/11806792 http://dx.doi.org/10.1186/cvm-2-4-171 Text en Copyright © 2001 BioMed Central Ltd |
spellingShingle | Review Suwaidi, Jassim Al Salam, Amar M Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease |
title | Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease |
title_full | Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease |
title_fullStr | Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease |
title_full_unstemmed | Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease |
title_short | Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease |
title_sort | platelet glycoprotein iib/iiia receptor blockade in coronary artery disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59641/ https://www.ncbi.nlm.nih.gov/pubmed/11806792 http://dx.doi.org/10.1186/cvm-2-4-171 |
work_keys_str_mv | AT suwaidijassimal plateletglycoproteiniibiiiareceptorblockadeincoronaryarterydisease AT salamamarm plateletglycoproteiniibiiiareceptorblockadeincoronaryarterydisease |